FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for immunotherapy. For this purpose, combination decitabine derivatives and anti-CTLA4 antibodies. Also disclosed are kit for immunotherapy, cancer treatment methods, use of a combination or kit for preparing a drug.
EFFECT: group of inventions enables carrying out immunotherapy, treating cancer in patients.
38 cl, 6 dwg, 5 tbl, 7 ex
| Title |
Year |
Author |
Number |
| USE OF THE PLINABULIN IN COMBINATION WITH THE IMMUNE RESPONSE CONTROL POINT INHIBITORS |
2016 |
- Khuan Lan
- Li Gloriya Tsi-Ji
|
RU2723021C2 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2817047C2 |
| COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT |
2016 |
|
RU2752506C2 |
| COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER |
2016 |
|
RU2786570C2 |
| NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2711380C2 |
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT |
2019 |
|
RU2794261C2 |
| HUMAN MONOCLONAL ANTIBODIES AGAINST PROGRAMMED DEATH 1 (PD-1) PROTEIN AND CANCER TREATMENT METHOD USING ANTI-PD-1-ANTIBODIES SEPARATELY OR COMBINED WITH OTHER IMMUNOTHERAPEUTIC AGENTS |
2013 |
- Korman Alan Dzh.
- Srinivasan Mokhan
- Van Chanyuj
- Selbi Mark Dzh.
- Chen Bin
- Kardarelli Zhozefin M.
|
RU2599417C2 |
| HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR PROGRAMMED CELL DEATH 1 (PD1) PROTEIN AND METHODS OF TREATING CANCER WITH USING ANTI-PD1 ANTIBODIES EITHER INDIVIDUALLY, OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTIC AGENTS |
2006 |
- Korman Alan Dzh.
- Srinivasan Mokhan
- Van Chanjuj
- Selbi Mark Dzh.
- Chehn' Bin
- Kardarelli Zhozefin M.
- Khuan Khajchun'
|
RU2494107C2 |
| CONTROL POINT INHIBITOR AND WHOLE MYCOBACTERIAL CELLS FOR USE IN CANCER THERAPY |
2016 |
- Akle Charles
- Brunet Laura Rosa
|
RU2733033C2 |
| THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS THEREOF WITH ANTICANCER AGENTS |
2019 |
- Crosignani, Stefano
- Dickinson, Paul
- De Matas, Marcel
- Houthuys, Erica Joke Katelijne Heleen
- Marillier, Reece Gerrad
- Martinoli, Chiara
- De Henau, Olivier
- Driessens, Gregory
|
RU2824502C2 |
